In short. Botulinum toxin for hyperhidrosis is an injectable treatment that reduces excessive focal sweating of the underarms, palms and soles by blocking the signal that activates sweat glands. Relief typically lasts six to nine months in the underarms and somewhat less in the palms and soles. It reduces sweating but does not cure the underlying tendency.
Key points
- Treatment is established for focal sweating of the underarms, palms and soles, not for generalised sweating.
- It blocks the signal that activates sweat glands locally, but the glands are not destroyed.
- Relief typically lasts six to nine months in the underarms, somewhat less in the palms and soles.
- Palm treatment can cause temporary weakness of grip and fine finger movements.
- A minority notice compensatory sweating in untreated areas, which is usually mild.
Why the diagnosis is checked before injection
Hyperhidrosis, sweating far beyond what temperature or activity explains, can dominate daily life, from soaked clothing to reluctance to shake hands. Primary focal hyperhidrosis typically begins in youth, affects specific body areas symmetrically, and stops during sleep. Sweating that is generalised, new in adulthood, one-sided, or accompanied by other symptoms may be secondary, driven by medication, hormonal conditions, or illness, and needs medical investigation rather than symptomatic treatment. A proper assessment separates the two before any injection is offered. When strong antiperspirants and other first-line measures are not enough, botulinum toxin injections are a well-established medical treatment for focal sweating of the underarms, palms, and soles. They reduce sweating reliably for months at a time but do not cure the underlying tendency.
How the toxin reduces sweating
Sweat glands are activated by the same chemical signal that botulinum toxin blocks in muscle. Injected in a grid of tiny deposits just under the skin of the affected area, the toxin reduces that signal locally, so the treated glands produce far less sweat. The glands are not destroyed; as the effect wears off, sweating gradually returns and treatment can be repeated.
Which areas respond most reliably?
Underarms respond most reliably, with most people achieving a major reduction in sweating. Palms and soles also respond well but are more uncomfortable to treat, and palm treatment can cause temporary weakness of grip and fine finger movements, a real trade-off for people who rely on manual dexterity. Relief typically lasts six to nine months in the underarms and somewhat less in the palms and soles.
| Area | How it responds | How long relief lasts | The trade-off to weigh |
|---|---|---|---|
| Underarms | Most reliable, with a major reduction for most people | Six to nine months | Temporary soreness and bruising at injection points |
| Palms | Responds well | Somewhat less than six to nine months | Temporary weakness of grip and fine finger movements |
| Soles | Responds well | Somewhat less than six to nine months | More uncomfortable to treat |
| Untreated areas | No effect by design | Not applicable | Compensatory sweating, usually mild |
| Generalised or secondary sweating | Not the target of this treatment | Not applicable | Medical investigation first |
How is the treatment mapped and planned?
Assessment confirms primary focal hyperhidrosis, excludes secondary causes, and discusses the honest trade-offs, including the possibility of compensatory sweating elsewhere. A starch-iodine test can map the exact sweating area so only active zones are treated. Injection follows the map in a fine grid, with comfort measures for sensitive areas. Review at four to six weeks documents the reduction and plans maintenance, usually at six-to-nine-month intervals.
What happens after the injections?
There is no downtime; normal activity resumes immediately. Reduced sweating develops over several days and reaches full effect by about two weeks. Because results fade gradually, most people schedule repeat treatment once or twice a year rather than waiting for full return of symptoms.
The side effects and trade-offs to weigh
Common effects are temporary: injection-point soreness, bruising, and, with palm treatment, transient hand weakness. A minority of people notice increased sweating in untreated areas, compensatory sweating, which is usually mild but should be discussed before treatment. Rarely, flu-like symptoms occur in the first days. Serious reactions are uncommon, but treatment should be deferred in pregnancy and breastfeeding and avoided with certain neuromuscular conditions.
Where the treatment sits in the ladder
Injection therapy sits within a ladder that starts with clinical-strength antiperspirants and may include oral medication, iontophoresis for hands and feet, or other procedures for severe cases. Regular follow-up keeps the plan proportionate to how much the condition is actually affecting life.
When to seek medical review
Sweating that is generalised, began suddenly in adulthood, occurs at night, or comes with weight loss, palpitations, or fever needs medical investigation first. Marked hand weakness, or any swallowing or breathing difficulty after treatment, needs prompt medical review. Treatment should be deferred or avoided in pregnancy, breastfeeding, or a neuromuscular condition.
Sources
Internal links
Frequently asked questions
Does botulinum toxin cure excessive sweating?
No. It reduces sweating reliably for months at a time by blocking the signal that activates the sweat glands, but the glands are not destroyed and the underlying tendency is not cured. As the effect wears off, sweating returns and treatment can be repeated.
How long does underarm treatment last compared with the palms?
Relief typically lasts six to nine months in the underarms and somewhat less in the palms and soles. Most people schedule repeat treatment once or twice a year rather than waiting for symptoms to return fully.
What is the main trade-off of treating sweaty palms?
Palm treatment is more uncomfortable and can cause temporary weakness of grip and fine finger movements, which matters for anyone who relies on manual dexterity. A minority of people also notice increased sweating in untreated areas.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.